NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii

Journal of Immunology

Volumn 175, Issue 2, 2005, Pages 899-908

  Ronet, Catherine ^a   Darche, Sylvie ^a   De Moraes, Maria Leite ^b   Miyake, Sachiko ^c   Yamamura, Takashi ^c   Louis, Jacques A ^a   Kasper, Lloyd H ^d   Buzoni Gatel, Dominique ^a  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; BASILIXIMAB; GAMMA INTERFERON; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMERA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENTERITIS; FEMALE; GENE OVEREXPRESSION; ILEITIS; IMMUNOPATHOLOGY; INTERFERON PRODUCTION; LAMINA PROPRIA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TOXOPLASMA GONDII;

EID: 23244434262     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.2.899     Document Type: Article

References (57)

1. Bendelac, A., M. Rivera, S. Park, and J. Roark. 1997. Mouse CD1-specific NK1 T cells: development specificity, and function. Annu. Rev. Immunol. 15: 535-562.
2. Kronenberg, M., L. Brossay, Z. Kurepa, and J. Forman. 1999. Conserved lipid and peptide presentation functions of nonclassical class 1 molecules. Immunol. Today 20: 515-521.
3. + T cells. Eur. J. Immunol. 30: 2488-2496.
4. Voyle, R., F. Beermann, R. Lees, J. Schumann, J. Zimmer, W. Held, and H. MacDonald. 2003. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D. J. Exp. Med. 197: 919-925.
5. Porcelli, S. A., and R. L. Modlin. 1999. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17: 297-329.
6. - T cells. J. Exp. Med. 186: 109-120.
7. Mendiratta, S., W. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6: 469-477.
8. + T cells. Nature 372: 691-694.
9. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, H. Koseki, and M. Taniguchi. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278: 1626-1629.
10. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J. Immunol. 159: 2240-2249.
11. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2: 557-568.
12. Oki, S., A. Chiba, T. Yamamura, and S. Miyake. 2004. The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J. Clin. Invest. 113: 1631-1640.
13. Singh, N., S. Hong, D. Scherer, I. Serizawa, N. Burdin, M. Kronenberg, Y. Koezuka, and L. van Kaer. 1999. Activation of NKT cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a TH2 phenotype. J. Immunol. 163: 2373-2377.
14. Nishimura, T., H. Kitamura, K. Iwakabe, T. Yahata, A. Ohta, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, et al. 2000. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12: 987-994.
15. Gonzalez-Aseguinolaza, G., L. Van Kaer, C. C. Bergmann, J. M. Wilson, J. Schmieg, M. Kronenberg, T. Nakayama, M. Taniguchi, Y. Koezuka, and M. Tsuji. 2002. Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 195: 617-624.
16. Eberl, G., and H. R. MacDonald. 2000. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30: 985-992.
17. Naumov, Y. N., K. S. Bahjat, R. Gausling, R. Abraham, M. A. Exley, Y. Koezuka, S. B. Balk, J. L. Strominger, M. Clare-Salzer, and S. B. Wilson. 2001. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 98: 13838-13843.
18. -(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187: 1047-1056.
19. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191: 1895-1903.
20. Kakimi, K., L. G. Guidotti, Y. Koezuka, and F. V. Chisari. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192: 921-930.
21. Hansen, D. S., and L. Schofield. 2004. Regulation of immunity and pathogenesis in infectious diseases by CD1d-restricted NKT cells. Int. J. Parasitol. 34: 15-25.
22. + NKT cells during HIV type 1 infection. J. Immunol. 168: 1490-1495.
23. + effector function against intracellular infection. J. Exp. Med. 184: 131-139.
24. + T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen. J. Immunol. 168: 2988-2996.
25. Bendelac, A., R. Hunziker, and O. Lantz. 1996. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J. Exp. Med. 184: 1285-1293.
26. Kawakami, N., N. Sakane, F. Nishizawa, M. Iwao, S. Fukada, K. Tsujikawa, Y. Kohama, M. Ikawa, M. Okabe, and H. Yamamoto. 1999. Green fluorescent protein-transgenic mice: immune functions and their application to studies of lymphocyte development. Immunol. Lett. 70: 165-171.
27. + T cell-dependent, interferon-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184: 597-607.
28. Buzoni-Gatel, D., H. Debbabi, F. Mennechet, V. Martin, A. Lepage, J. Schwartzman, and L. Kasper. 2001. Murine ileitis after intracellular parasite infection is controlled by TGF-β-producing intraepithelial lymphocytes. Gastroenterology 120: 914-924.
29. + NK T cells. J. Immunol. 166: 1755-1762.
30. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192: 741-754.
31. Overbergh, L., D. Valckx, M. Waer, and C. Mathieu. 1999. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11: 305-312.
32. Costa, J., C. Pautas, P. Ernault, F. Foulet, C. Cordonnier, and S. Bretagne. 2000. Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes. J. Clin. Microbiol. 38: 2929-2932.
33. Allez, M., and L. Mayer. 2004. Regulatory T cells: peace keepers in the gut. Inflamm. Bowel Dis. 10: 666-676.
34. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. Blumberg, and A. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230.
35. Guy-Grand, D., B. Cuenod-Jabri, M. Malassis-Seris, F. Selz, and P. Vassalli. 1996. Complexity of the mouse gut T cell immune system: identification of two distinct natural killer T cell intraepithelial lineages. Eur. J. Immunol. 26: 2248-2256.
36. + natural T cells in the large intestine. Eur. J. Immunol. 31: 3361-3369.
37. Denkers, E., L. Del Rio, and S. Bennouna. 2003. Neutrophil production of IL-12 and other cytokines during microbial infection. Chem. Immunol. Allergy 83: 95-114.
38. Leite-de-Moraes, M., G. Moreau, A. Arnould, F. Machavoine, C. Garcia, M. Papiernik, and M. Dy. 1998. IL-4-producing NK T cells are biased towards IFN-γ production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells. Eur. J. Immunol. 28: 1507-1515.
39. +NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 163: 93-101.
40. Brigl, M., L. Bry, S. Kent, J. Gumperz, and M. B. Brenner. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4: 1230-1237.
41. Kasper, L. 1989. Identification of stage-specific antigens of Toxoplasma gondii. Infect. Immun. 57: 668-672.
42. Khan, I., M. Eckel, E. Pfefferkorn, and L. Kasper. 1988. Production of γ interferon by cultured human lymphocytes stimulated with a purified membrane protein (P30) from Toxoplasma gondii. J. Infect. Dis. 157: 979-984.
43. Rachinel, N., D. Buzoni-Gatel, C. Dutta, F. Mennechet, S. Luangsay, L. Minns, M. Grigg, S. Tomavo, J. Boothroyd, and L. Kasper. 2004. The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii. J. Immunol. 173: 2725-2735.
44. Blumberg, R., C. Therhost, P. Bleicher, F. McDermott, C. Allan, S. Landau, J. Trier, and S. Balk. 1991. Expression of a non polymorphic MHC class I-like molecule, CD1d by human intestinal epithelial cells. J. Immunol. 147: 2518-2524.
45. Colgan, S., R. Hershberg, G. Furutua, and R. Blumberg. 1999. Ligation of intestinal epithelial CD1d induces bioactive IL-10: Critical role of the cytoplasmic tail in autocrine signaling. Proc. Natl. Acad. Sci. USA 96: 13938-13943.
46. Godfrey, D., H. MacDonald, M. Kronenberg, M. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237.
47. Suzuki, Y., A. Sher, G. Yap, D. Park, L. Neyer, O. Liesenfeld, M. Fort, H. Kang, and E. Gufwoli. 2000. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 164: 5375-5382.
48. Roers, A., L. Siewe, E. Strittmatter, M. Decken, D. Schluter, W. Stenzel, A. D. Gruber, T. Krieg, K. Rajewsky, and W. Muller. 2004. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 200: 1289-1297.
49. Sharif, S., G. A. Arreaza, P. Zucker, Q. S. Mi, J. Sondhi, O. V. Naidenko, M. Kronenberg, Y. Koezuka, T. L. Delovitch, J. M. Gombert, et al. 2001. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 7: 1057-1062.
50. Singh, A., M. Wilson, S. Hong, D. Olivares-Villagomez, C. Du, A. Stanic, S. Joyce, S. Sriram, Y. Koezuka, and L. Van Kaer. 2001. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194: 1801-1811.
51. + T regulatory cells following antigen inoculation in an immune-privileged site. J. Immunol. 171: 1266-1271.
52. Fujii, S.-I., K. Shimizu, C. Smith, L. Bonifaz, and R. M. Steinman. 2003. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198: 267-279.
53. Groux, H., N. Fournier, and F. Cottrez. 2004. Role of dendritic cells in the generation of regulatory T cells. Semin. Immunol. 16: 99-106.
54. Nickdel, M. B., R. E. Lyons, F. Roberts, F. Brombacher, C. A. Hunter, J. Alexander, and C. W. Roberts. 2004. Intestinal pathology during acute toxoplasmosis is IL-4 dependent and unrelated to parasite burden. Parasite Immunol. 26: 75-82.
55. Ueno, Y., S. Tanaka, M. Sumii, S. Miyake, S. Tazuma, M. Taniguchi, T. Yamamura, and K. Chayama. 2005. Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of Vα14 natural killer T cells in mice. Inflamm. Bowel Dis. 11: 35-41.
56. Saubermann, L. J., P. Beck, Y. P. De long, R. S. Pitman, M. S. Ryan, H. S. Kim, M. Exley, S. Snapper, S. P. Balk, S. J. Hagen, O. Kanauchi, K. Motoki, T. Sakai, C. Terhorst, Y. Koezuka, D. K. Podolsky, and R. S. Blumberg. 2000. Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 119: 119-128.
57. Heller, F., I. J. Fuss, E. E. Nieuwenhuis, R. S. Blumberg, and W. Strober. 2002. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17: 629-638.